2-Bromo-6-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methylpyridine (S2). To a dry 20 mL microwave vial equipped with a magnetic stir bar was added 6-bromo-4-methyl-pyridin-2-ylamine (935 mg, 5.0 mmol) dissolved in toluene (15 mL). 2,5-Hexadione (687 mg, 6.0 mmol) and p-toluenesulfonic acid (0.20 g) were then added, and the vial was capped with a rubber septum. The vial was heated in the microwave irradiator for 60 min at 150 °C. The reaction mixture was cooled, concentrated in vacuo, and purified by flash column chromatography to give the title product (1.09 g, 82% 
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Inhibitor Complex Crystal Preparation.
The rat nNOS or bovine eNOS heme domain proteins used for crystallographic studies were produced by limited trypsin digest from the corresponding full length enzymes and further purified through a Superdex 200 gel filtration column (GE Healthcare) as described previously. 1, 2 The nNOS heme domain (at 9 mg/mL containing 20 mM histidine), or the eNOS heme domain (at 12 mg/mL containing 2 mM imidazole) was used for the sitting drop vapor diffusion crystallization setup under conditions previously reported.
i,ii Fresh crystals (1-2 days old) were first passed stepwise through cryoprotectant solutions and then soaked with 10 mM inhibitor for 4-6 h at 4 ˚C before being flash cooled with liquid nitrogen.
3. X-ray Diffraction Data Collection, Data Processing, and Structural Refinement. The cryogenic (100 K) X-ray diffraction data were collected remotely at the Stanford Synchrotron Radiation Lightsource (SSRL) or Advanced Light Source (ALS) through the data collection control software Blu-Ice 3 and a crystal mounting robot. When a Q315r CCD detector was used, 90-100˚ of data were typically collected with 0.5˚ per frame. If a Pilatus pixel array detector was used, 140-160˚ of fine-sliced data were collected with 0.2˚ per frame. Raw CCD data frames were indexed, integrated, and scaled using HKL2000, 4 but the pixel array data were processed with XDS 5 and scaled with Aimless. 6 The binding of inhibitors was detected by the initial difference Fourier maps calculated with REFMAC. 7 The inhibitor molecules were then modeled in COOT 8 and refined using REFMAC. Disordering in portions of inhibitors bound in the NOS active sites was often observed, sometimes resulting in poor density quality. However, partial structural features usually could still be visible if the contour level of the sigmaA weighted 2m|Fo| -D|Fc| map dropped to 0.5 σ, which afforded the building of reasonable models into the disordered regions. Water molecules were added in REFMAC and checked by COOT. The TLS 9 protocol was implemented in the final stage of refinements with each subunit as one TLS group. The omit Fo -Fc density maps were calculated by repeating the last round of TLS refinement with inhibitor coordinate removed from the input PDB file to generate the map coefficients DELFWT and PHDELWT. The refined structures were validated in COOT before deposition in the RCSB protein data bank. The crystallographic data collection and structure refinement statistics are summarized in Table S1 of the Supporting Information, with the PDB accession codes included. 2 R free was calculated with the 5% of reflections set aside throughout the refinement. The set of reflections for the R free calculation were kept the same for all data sets of each isoform according to those used in the data of the starting model.
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